Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price […]

Related Keywords

Texas , United States , John Militello , Mark Andrew White , Rocket Pharmaceuticals Inc , Allspring Global Investments Holdings , Torray Investment Partners , Rocket Pharmaceuticals Company Profile , Nasdaq , Analyst Recommendations For Rocket Pharmaceuticals , Jpmorgan Chase Co , News Ratings For Rocket Pharmaceuticals Daily , Institutional Investors Weigh In On Rocket Pharmaceuticals , Rocket Pharmaceuticals , Rocket Pharmaceuticals Stock Performance , Securities Exchange Commission , Principal Financial Group Inc , Needham Company , Cantor Fitzgerald , Get Free Report , Exchange Commission , Global Investments Holdings , Financial Group , Investment Partners , Teacher Retirement System , Retirement System , Get Free , Rocket Pharmaceuticals Daily ,